Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06285812 · ClinicalTrials.gov registry record
Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children
A clinical trial of Otitis Media Acute, sponsored by PhotoniCare.
- Active
- Registry status
- 700
- Enrollment target
- 7
- Study locations
NCT06285812: Active study of Otitis Media Acute, sponsored by PhotoniCare.
NCT06285812 is a study of Otitis Media Acute that is active but no longer recruiting, run by PhotoniCare. The registered enrollment target is 700 participants. The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06285812, a study of Otitis Media Acute, is active but no longer recruiting, sponsored by PhotoniCare.
- ACTIVE NOT RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 7
- Study locations
Study Summary
A pragmatic, mixed-method trial is to show the ability of OtoSight to change management of the pediatric patient presenting with ear pain in a way that improves patient outcomes and reduces costs.
Primary Outcome
Antibiotic stewardship
Conditions Studied
Interventions
- DEVICE OtoSight Middle Ear Scope
Study Locations (7)
Florida
- Abba Medical Group LLC - Miami
- AdventHealth Children's Research - Orlando
District of Columbia
- Children's National Hospital - Washington D.C.
New York
- Trillim Health - Rochester
Oregon
- Cyn3rgy Research - Gresham
South Carolina
- Carolina ENT - Orangeburg
Tennessee
- HealthStar Physicians - Morristown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2024-01-10 |
| Est. Completion | 2025-12-30 |
What the registry record for NCT06285812 still lists
NCT06285812 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Otitis Media Acute appearing as the primary indexed condition, and to 1 intervention - of which OtoSight Middle Ear Scope is the first listed.
NCT06285812 lists 7 locations in 6 states (Florida, District of Columbia, New York).
Frequently Asked Questions
What is clinical trial NCT06285812 about?
NCT06285812 is a clinical study titled "Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children". A pragmatic, mixed-method trial is to show the ability of OtoSight to change management of the pediatric patient presenting with ear pain in a way that improves patient outcomes and reduces costs.
What is the current status of trial NCT06285812?
This trial is currently active not recruiting. The enrollment target is 700 participants. The study started on 2024-01-10. Estimated completion is 2025-12-30.
What conditions does trial NCT06285812 study?
This clinical trial studies the following conditions: Otitis Media Acute.
What interventions are being tested in trial NCT06285812?
The interventions under investigation include: OtoSight Middle Ear Scope (DEVICE).
Who is sponsoring clinical trial NCT06285812?
This trial is sponsored by PhotoniCare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06285812 being conducted?
This trial has 7 study locations across District of Columbia, Florida, New York, Oregon, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Otitis Media Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI